Skip to main content

Biontech Se ADR(BNTX-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Volume
Day Low121.72
Day High125.05
Open:121.95
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

Download Premium PDFRefinitiv. Trademark. Data is Just the Beginning.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

Download Premium PDFStockCalc

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Download Premium PDFValueEngine

Press & news

Latest News

More Stories
Why Shares of BioNTech Slumped Monday
Motley Fool - Mon Mar 27, 2:06PM CDT
Motley Fool
Mon Mar 27, 2:06PM CDT
The company released fourth-quarter earnings.
Wall Street - shutterstock_253136563
Stocks See Support as Banking Stocks Gain
Barchart - Mon Mar 27, 10:07AM CDT
Barchart
Mon Mar 27, 10:07AM CDT
What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.13%. U.S. stock indexes this morning are mixed. The broader...
BioNTech Is Ripe For A Rebound In 2023 
MarketBeat - Mon Mar 27, 8:43AM CDT
MarketBeat
Mon Mar 27, 8:43AM CDT
BioNTech had a strong quarter and may become a takeover target due to its healthy pipeline and a looming patent cliff for big pharma.

Latest Articles

COVID-19 vaccine makers’ shares slump, but there’s upside as other products hit the market
Why high-risk, high-reward biotech sector may be poised for a bull run
Moderna sues Pfizer/BioNTech for patent infringement over COVID-19 vaccine
BioNTech reports strong first half, expects demand to grow
Market movers: Stocks that saw action on Monday - and why
Pfizer maintains sales forecasts for its COVID-19 vaccine, pill as pandemic curbs ease
Canadian Pfizer partner sues to head off patent lawsuit over COVID-19 vaccine
Don’t expect vaccine makers’ shares to jump despite continuing demand for boosters, treatments
Pfizer’s forecast for 2022 sales of its COVID-19 vaccine, antiviral pill falls short of estimates
Market movers: Stocks that saw action on Wednesday - and why
Early BioNTech, Pfizer data suggest boosters may protect against infection from Omicron variant
COVID-19 vaccine makers start work on Omicron-tailored shots

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2023.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2023 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.